employee uptake wellness wallet glp-1 weight loss programs Weight-Loss Coverage: LSAs vs. Stipends GLP-1s Spark Progress, Wellhub Makes

Operations and President of Novo Nordisk Inc

Coverage, copays and eligibility vary by plan

Key Contribution This study demonstrates that GLP-1 receptor agonist therapy is associated with reduced risks of urinary retention and urinary tract infection in non-diabetic adults receiving BTX-A for overactive bladder, independent of weight loss

Wadden and colleagues assessed changes in depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9) and suicidal ideation or behaviors using the Columbia Suicide Severity Rating Scale in participants with overweight or obesity using semaglutide 2.4 mg or placebo

Semaglutide is a pure GLP-1 receptor agonist, meaning it targets only the GLP-1 pathway

But take it from 2 weight loss dietitians in Orlando